PolyNovo Limited (ASX: PNV) — Stock Profile

PolyNovo Limited designs, manufactures, and sells biodegradable medical devices across Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, and Hong Kong. The company's commercial focus centres on wound care and tissue regeneration, with its pipeline extending into hernia repair, abdominal wall reconstruction, and plastics and reconstructive device products.

Its flagship product, NovoSorb Biodegradable Temporising Matrix, is a dermal matrix used to regenerate dermis lost through extensive surgery, trauma, or burn. The company is also developing NovoSorb MTX for single-stage grafting in burns, chronic, and surgical wounds, a Beta Cell implant designed as a novel intracutaneous ectopic pancreas for treating type 1 diabetes, and devices for ventral hernia and complex abdominal wall reconstruction. Formerly known as Calzada Limited, the company adopted the PolyNovo name in November 2014 and was originally incorporated in 1998. It is headquartered in Port Melbourne, Australia.